Your browser doesn't support javascript.
loading
HLA-DR Marks Recently Divided Antigen-Specific Effector CD4 T Cells in Active Tuberculosis Patients.
Tippalagama, Rashmi; Singhania, Akul; Dubelko, Paige; Lindestam Arlehamn, Cecilia S; Crinklaw, Austin; Pomaznoy, Mikhail; Seumois, Gregory; deSilva, Aruna D; Premawansa, Sunil; Vidanagama, Dhammika; Gunasena, Bandu; Goonawardhana, N D Suraj; Ariyaratne, Dinuka; Scriba, Thomas J; Gilman, Robert H; Saito, Mayuko; Taplitz, Randy; Vijayanand, Pandurangan; Sette, Alessandro; Peters, Bjoern; Burel, Julie G.
Afiliação
  • Tippalagama R; Vaccine Discovery Division, La Jolla Institute for Immunology, La Jolla, CA.
  • Singhania A; Vaccine Discovery Division, La Jolla Institute for Immunology, La Jolla, CA.
  • Dubelko P; Vaccine Discovery Division, La Jolla Institute for Immunology, La Jolla, CA.
  • Lindestam Arlehamn CS; Vaccine Discovery Division, La Jolla Institute for Immunology, La Jolla, CA.
  • Crinklaw A; Vaccine Discovery Division, La Jolla Institute for Immunology, La Jolla, CA.
  • Pomaznoy M; Vaccine Discovery Division, La Jolla Institute for Immunology, La Jolla, CA.
  • Seumois G; Vaccine Discovery Division, La Jolla Institute for Immunology, La Jolla, CA.
  • deSilva AD; Vaccine Discovery Division, La Jolla Institute for Immunology, La Jolla, CA.
  • Premawansa S; Faculty of Medicine, General Sir John Kotelawala Defense University, Ratmalana, Sri Lanka.
  • Vidanagama D; Faculty of Science, University of Colombo, Colombo, Sri Lanka.
  • Gunasena B; National Tuberculosis Reference Laboratory, Welisara, Sri Lanka.
  • Goonawardhana NDS; National Hospital for Respiratory Diseases, Welisara, Sri Lanka.
  • Ariyaratne D; Faculty of Medicine, General Sir John Kotelawala Defense University, Ratmalana, Sri Lanka.
  • Scriba TJ; Faculty of Medicine, General Sir John Kotelawala Defense University, Ratmalana, Sri Lanka.
  • Gilman RH; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine, Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa.
  • Saito M; Johns Hopkins School of Public Health, Baltimore, MD.
  • Taplitz R; Universidad Peruana Cayetano Heredia, Lima, Peru.
  • Vijayanand P; Department of Virology, Tohoku University Graduate School of Medicine, Sendai, Japan.
  • Sette A; Department of Medicine, City of Hope National Medical Center, Duarte, CA; and.
  • Peters B; Vaccine Discovery Division, La Jolla Institute for Immunology, La Jolla, CA.
  • Burel JG; Department of Medicine, University of California San Diego, La Jolla, CA.
J Immunol ; 207(2): 523-533, 2021 07 15.
Article em En | MEDLINE | ID: mdl-34193602
ABSTRACT
Upon Ag encounter, T cells can rapidly divide and form an effector population, which plays an important role in fighting acute infections. In humans, little is known about the molecular markers that distinguish such effector cells from other T cell populations. To address this, we investigated the molecular profile of T cells present in individuals with active tuberculosis (ATB), where we expect Ag encounter and expansion of effector cells to occur at higher frequency in contrast to Mycobacterium tuberculosis-sensitized healthy IGRA+ individuals. We found that the frequency of HLA-DR+ cells was increased in circulating CD4 T cells of ATB patients, and was dominantly expressed in M. tuberculosis Ag-specific CD4 T cells. We tested and confirmed that HLA-DR is a marker of recently divided CD4 T cells upon M. tuberculosis Ag exposure using an in vitro model examining the response of resting memory T cells from healthy IGRA+ to Ags. Thus, HLA-DR marks a CD4 T cell population that can be directly detected ex vivo in human peripheral blood, whose frequency is increased during ATB disease and contains recently divided Ag-specific effector T cells. These findings will facilitate the monitoring and study of disease-specific effector T cell responses in the context of ATB and other infections.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tuberculose / Mycobacterium tuberculosis Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tuberculose / Mycobacterium tuberculosis Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article